Healthcare-associated infections in Iranian pediatric and adult intensive care units: A comprehensive review of risk factors,etiology,molecular epidemiology,antimicrobial sensitivity,and prevention strategies during the COVID-19 pandemic
Restricted accessReview articleFirst published online August, 2025
Healthcare-associated infections in Iranian pediatric and adult intensive care units: A comprehensive review of risk factors,etiology,molecular epidemiology,antimicrobial sensitivity,and prevention strategies during the COVID-19 pandemic
The current review article provides a comprehensive analysis of nosocomial infections in pediatric and adult intensive care units (ICUs) in Iran. We examine the risk factors and etiology of nosocomial infections, with a particular focus on molecular epidemiology and antimicrobial sensitivity. In this article, we explore a range of prevention strategies, including hand hygiene, personal protective equipment, environmental cleaning, antibiotic stewardship, education, and training. Moreover, we discuss the impact of the COVID-19 pandemic on infection control measures in ICUs and provide valuable insights for healthcare professionals and policymakers seeking to address this critical public health issue. In conclusion, this review article can serve as a valuable resource for those interested in understanding and improving infection control in ICUs and beyond.
KollefMHTorresAShorrAFMartin-LoechesIMicekST. Nosocomial infection. Crit Care Med2021;49(2):169-187.
2.
RaoofiSPashazadeh KanFRafieiS, et al.Global prevalence of nosocomial infection: A systematic review and meta-analysis. PloS One2023;18(1):e0274248.
3.
DuQZhangDHuW, et al.Nosocomial infection of COVID-19: A new challenge for healthcare professionals. Int J Mol Med2021;47(4):1.
4.
NejatNJadidiAHezaveAKPourSMA. Prevention and treatment of COVID-19 using traditional and folk medicine: A content analysis study. Ethiop J Health Sci2021;31(6):1089–1098.
5.
EdwardsonSCairnsC. Nosocomial infections in the ICU. Anaesth Intensive Care Med2019;20(1):14-18.
6.
MohammadiAKhatamiFAzimbeikZKhajaviAAlooshMAghamirSMK. Hospital-acquired infections in a tertiary hospital in Iran before and during the COVID-19 pandemic. Wien Med Wochenschr2022;172(9):220-226.
7.
MarkwartRSaitoHHarderT, et al.Epidemiology and burden of sepsis acquired in hospitals and intensive care units: A systematic review and meta-analysis. Intensive Care Med2020;46(2):1536-1551.
8.
BonellAAzarrafiyRHuongVTL, et al.A systematic review and meta-analysis of ventilator-associated pneumonia in adults in Asia: An analysis of national income level on incidence and etiology. Clin Infect Dis2019;68(3):511-518.
9.
ÇelikBÖzkanBSamsaHSavH. Predictive values of biomarkers in identifying bacterial and fungal nosocomial bloodstream infections in children. Cocuk Enfeksiyon Dergisi. 2022;16(2):E63-E68.
10.
JabarpourMDehghanMAfsharipourG, et al.The impact of COVID-19 outbreak on nosocomial infection rate: a case of Iran. Can J Infect Dis Med Microbiol2021;2021(1):1-6.
11.
AnsariSHaysJPKempA, et al.The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: An AMR insights global perspective. JAC Antimicrob Resist2021;3(2):dlab038.
12.
AminiNYazdannikASafarabadiMHaroraniMRezaeiK. Effect of nebulized Eucalyptus on arterial blood gases and physiologic indexes of mechanical ventilated patients: A randomized clinical trial. J Caring Sci2022;11(4):217-223.
13.
RafieiSNejatifarZSoheyliradRRaoofiSKanFPGhashghaeeA. Prevalence of Nosocomial Infections During the COVID-19 Pandemic: A Systematic Review and Meta-analysis. J Health Rep Technol2022;8(3):1-11.
14.
EshratiBAslHMAfhamiSPezeshkiZSeifiA. Health care-associated infections in Iran: A national update for the year 2015. Am J Infect Control2018;46(6):663-667.
15.
MotallebiradTTashakorAAbnikiRAzadiD. 15 Years of phenotypic and genotypic surveillance and antibiotic susceptibility pattern of actinomycetes (Mycobacterium, Nocardia, Rhodococcus, etc.) in clinical and environmental samples of Iran. Diagn Microbiol Infect Dis2023;9(1):116080.
16.
HaradaSUnoSAndoTIidaMTakanoYIshibashiY, et al. (eds) Control of a nosocomial outbreak of COVID-19 in a university hospital. Open forum infectious diseases. Oxford University Press2020.
17.
ChengKHeMShuQWuMChenCXueY. Analysis of the risk factors for nosocomial bacterial infection in patients with COVID-19 in a tertiary hospital. Risk Manag Healthc Policy2020;13(6):2593-2599.
18.
GrasselliGScaravilliVMangioniD, et al.Hospital-acquired infections in critically ill patients with COVID-19. Chest. 2021;160(2):454-465.
19.
HeYLiWWangZChenHTianLLiuD. Nosocomial infection among patients with COVID-19: A retrospective data analysis of 918 cases from a single center in Wuhan, China. Infect. Control Hosp. Epidemiol2020;41(8):982-983.
20.
Muniz-RodriguezKFungIC-HFerdosiSR, et al.Transmission potential of COVID-19 in Iran. medRxiv. 2020:2020.03. 08.20030643.
21.
AhadiMShamsAHYadollahiM. Effect of COVID-19 pneumonia infection control protocols on nosocomial infection incidence in trauma patients. Chin J Traumatol2023;26(5):284-289.
22.
BardiTPintadoVGomez-RojoM, et al.Nosocomial infections associated to COVID-19 in the intensive care unit: Clinical characteristics and outcome. Eur J Clin Microbiol Infect Dis2021;40(3):495-502.
23.
OngCCHFarhanahSLinnKZ, et al.Nosocomial infections among COVID-19 patients: An analysis of intensive care unit surveillance data. Antimicrob Resist Infect Control2021;10(1):1-5.
24.
NasiriNShahrbabakiPMSharifiA, et al.Barriers and Problems in Implementing Health-Associated Infections Surveillance Systems in Iran: A Qualitative Study. Med J Islam Repub Iran2023;37(1):1-8.
25.
AkbariMDidehdarMNazariMAzadiD. Pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 symptoms in Iran. Future Virol2022;17(1):13-18.
26.
SharifipourEShamsSEsmkhaniM, et al.Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infect Dis2020;20(1):1-7.
27.
LansburyLLimBBaskaranVLimWS. Co-infections in people with COVID-19: A systematic review and meta-analysis. J Infect2020;81(2):266-275.
28.
JadidiARezaei AshtianiAKhanmohamadi HezavehAAghaepourSM. Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of restless legs syndrome: A randomized controlled clinical trial. BMC Complement Med Ther2023;23(1):1-6.
29.
YangSHuaMLiuX, et al.Bacterial and fungal co-infections among COVID-19 patients in intensive care unit. Microbes Infect2021;23(4-5):104806.
30.
AzadiDShojaeiH. The role of the laboratory in the diagnosis of tuberculosis. Iran J Med Microbiol. 2016;10(2):1-15.
31.
HeidariRFarajzadeh SheikhAHashemzadehMFarshadzadehZSalmanzadehSSakiM. Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in southwestern Iran. Mol Biol Rep2022;49(5):3811-3822.
32.
PollyMde AlmeidaBLLennonRPCortêsMFCostaSFGuimarãesT. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil. Am J Infect Control2022;50(1):32-38.
33.
GhanizadehANajafizadeMRashkiSMarzhoseyniZMotallebiM. Genetic diversity, antimicrobial resistance pattern, and biofilm formation in Klebsiella pneumoniae isolated from patients with coronavirus disease 2019 (COVID-19) and ventilator-associated pneumonia. BioMed Res Int2021;2021(2):1-11.
34.
AkramiSMontazeriEASakiM, et al.Bacterial profiles and their antibiotic resistance background in superinfections caused by multidrug-resistant bacteria among COVID-19 ICU patients from southwest Iran. J Med Virol2023;95(1):e28403.
35.
AbdollahiASalehiMAhmadiA, et al.Detecting Pathogenic Agents in Mechanically-Ventilated, Critically-Ill COVID-19 Patients with Ventilator-Associated Pneumonia. Arch Clin Infect Dis2023;18(6):2-8.
36.
DonàDDi ChiaraCSharlandM. Multi-drug-resistant infections in the COVID-19 era: A framework for considering the potential impact. J Hosp Infect. 2020;106(1):198-199.
37.
ZandFVakiliHAsmarianN, et al.Unintended impact of COVID-19 pandemic on the rate of catheter related nosocomial infections and incidence of multiple drug resistance pathogens in three intensive care units not allocated to COVID-19 patients in a large teaching hospital. BMC Infect Dis2023;23(1):1-11.
38.
ShbakloNCorcioneSVicentiniC, et al.An observational study of MDR hospital-acquired infections and antibiotic use during COVID-19 pandemic: A call for antimicrobial stewardship programs. Antibiotics. 2022;11(5):695.
39.
SiavashifarMRezaeiFMotallebiradT, et al.Species diversity and molecular analysis of opportunistic Mycobacterium, Nocardia and Rhodococcus isolated from the hospital environment in a developing country, a potential resources for nosocomial infection. Genes Environ2021;43(1):1-12.
40.
MurniIKDukeTKinneySDaleyAJSoenartoY. Reducing hospital-acquired infections and improving the rational use of antibiotics in a developing country: An effectiveness study. Arch Dis Child2015;100(5):454-459.
41.
KayeADOkeaguCNPhamAD, et al.Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectives. Best Pract Res Clin Anaesthesiol2021;35(3):293-306.
42.
TessemaGAKinfuYDachewBA, et al.The COVID-19 pandemic and healthcare systems in Africa: A scoping review of preparedness, impact and response. BMJ Global Health. 2021;6(12):e007179.
43.
AzakESertcelikAErsozG, et al.Evaluation of the implementation of WHO infection prevention and control core components in Turkish health care facilities: Results from a WHO infection prevention and control assessment framework (IPCAF)—based survey. Antimicrob Resist Infect Control. 2023;12(1):11.
44.
AlzunitanMAEdmondMBAlsuhaibaniMASamuelsonRJSchweizerMLMarraAR. Positive deviance in infection prevention and control: A systematic literature review. Infect Control Hosp Epidemiol2022;43(3):358-365.
45.
AshtianiARJadidiAHezaveAK, et al.An analgesic effect of Stachys lavandulifolia in patients with migraine: A double-blind randomised clinical trial study. Adv Hum Biol2019;9(1):76-79.
